Calton & Associates Inc. Invests $217,000 in Synopsys, Inc. (SNPS) Stock
Calton & Associates Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 2,325 shares of the semiconductor company’s stock, valued at approximately $217,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Claraphi Advisory Network LLC purchased a new stake in Synopsys during the 4th quarter worth about $241,000. American Century Companies Inc. increased its holdings in Synopsys by 3.2% during the 4th quarter. American Century Companies Inc. now owns 362,471 shares of the semiconductor company’s stock worth $30,897,000 after purchasing an additional 11,084 shares during the period. Public Employees Retirement Association of Colorado increased its holdings in Synopsys by 3.3% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 29,681 shares of the semiconductor company’s stock worth $2,530,000 after purchasing an additional 954 shares during the period. CIBC Asset Management Inc increased its holdings in Synopsys by 20.7% during the 4th quarter. CIBC Asset Management Inc now owns 23,349 shares of the semiconductor company’s stock worth $1,990,000 after purchasing an additional 3,998 shares during the period. Finally, Everence Capital Management Inc. purchased a new stake in Synopsys during the 4th quarter worth about $249,000. 90.02% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have weighed in on SNPS. BidaskClub downgraded Synopsys from a “buy” rating to a “hold” rating in a report on Friday, February 2nd. JPMorgan Chase & Co. downgraded Synopsys from a “neutral” rating to an “underweight” rating and set a $87.00 price target on the stock. in a report on Tuesday, December 12th. Zacks Investment Research downgraded Synopsys from a “hold” rating to a “strong sell” rating in a report on Monday, December 4th. Needham & Company LLC increased their price objective on Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a report on Friday, December 1st. Finally, TheStreet downgraded Synopsys from an “a” rating to a “c+” rating in a report on Wednesday, November 29th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. Synopsys has an average rating of “Hold” and an average price target of $96.89.
Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, November 29th. The semiconductor company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.12. Synopsys had a return on equity of 5.78% and a net margin of 5.01%. The business had revenue of $696.60 million for the quarter, compared to the consensus estimate of $650.72 million. During the same quarter in the prior year, the business posted $0.77 EPS. The business’s revenue for the quarter was up 9.9% on a year-over-year basis. sell-side analysts forecast that Synopsys, Inc. will post 2.24 earnings per share for the current year.
In related news, Director Steven Walske sold 4,545 shares of the firm’s stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $90.12, for a total transaction of $409,595.40. Following the transaction, the director now owns 14,988 shares in the company, valued at approximately $1,350,718.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel John F. Runkel, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $88.00, for a total value of $880,000.00. Following the transaction, the general counsel now owns 18,742 shares in the company, valued at approximately $1,649,296. The disclosure for this sale can be found here. In the last quarter, insiders sold 65,442 shares of company stock worth $5,779,693. Company insiders own 1.82% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Calton & Associates Inc. Invests $217,000 in Synopsys, Inc. (SNPS) Stock” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://theolympiareport.com/2018/02/11/calton-associates-inc-invests-217000-in-synopsys-inc-snps-stock.html.
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.